Related Experiment Video
Updated: Mar 29, 2026

Standardized Hemorrhagic Shock Induction Guided by Cerebral Oximetry and Extended Hemodynamic Monitoring in Pigs
Published on: May 21, 2019
Who benefits more from hemodynamically guided hypotensive therapy? The experience from two randomized, prospective
Paweł Krzesiński1, Grzegorz Gielerak2, Adam Stańczyk2
1Department of Cardiology and Internal Diseases, Military Institute of Medicine, Szaserow Street 128, 04-141 Warsaw 44, Poland pkrzesinski@wim.mil.pl.
Insights
Impedance cardiography (ICG)-guided antihypertensive therapy significantly reduces blood pressure (BP) more effectively than empiric treatment, particularly in patients with more elevated baseline BP. For those with slightly increased BP, both approaches show comparable results.
Area of Science:
- Cardiology
- Clinical Trials
- Hypertension Management
Background:
- Arterial hypertension (AH) management can be complex due to factors like fluid retention and vascular resistance.
- Impedance cardiography (ICG) aids in personalizing antihypertensive therapy, but its specific benefits for patient subgroups are not fully understood.
Purpose of the Study:
- To evaluate the effectiveness of ICG-guided antihypertensive therapy compared to empiric treatment over 12 weeks.
- To determine if baseline blood pressure (BP) influences the benefit of ICG-guided therapy.
Main Methods:
- A randomized controlled trial involving 272 patients with AH.
- Patients received either empiric (GE) or ICG-guided (HD) antihypertensive therapy.
- Subgroup analysis based on median mean blood pressure (MBP) of 110 mmHg: slightly increased BP (SI_BP) and more increased BP (MI_BP).
Main Results:
- ICG-guided therapy (HD) demonstrated superior BP reduction in the MI_BP subgroup compared to empiric therapy (GE).
- Significant differences favoring HD were observed in office and 24-h SBP and DBP changes, as well as the percentage of patients achieving ≥10 mmHg BP reduction.
- No significant differences were found between GE and HD in the SI_BP subgroup.
Conclusions:
- Hemodynamically guided pharmacotherapy, particularly using ICG, leads to greater BP reduction.
- The benefit of ICG-guided therapy is more pronounced in patients with higher baseline BP.
- For patients with slightly elevated BP, empiric therapy may be as effective as ICG-guided treatment.
Objectives:
Arterial hypertension (AH) may be related to fluid retention, increased vascular resistance or hyperdynamic heart function. Impedance cardiography (ICG) is shown to be useful in the individualization of antihypertensive therapy but little is known about who most benefits from this therapeutic approach. The aim of this analysis was to estimate the effectiveness of ICG-guided antihypertensive therapy with respect to baseline blood pressure (BP) from the perspective of 12 weeks' observation in randomized, prospective and controlled trials.
Methods:
This analysis involved 272 patients (average age: 44.1 ± 10.8 years) with AH. After baseline evaluation, including: office BP measurement (systolic, SBP; diastolic, DBP; mean, MBP) and ambulatory BP monitoring (mean 24-h SBP, mean 24-h DBP) the subjects were randomly assigned to groups of empiric [GE] and ICG-guided antihypertensive therapy [HD]. The results were evaluated separately in subgroups derived from median of MBP (110 mmHg): with slightly increased ('SI_BP') and more increased BP ('MI_BP'). The comparative analysis included absolute change in BP (d_OSBP, d_ODBP, d_24-h SBP, d_24-h DBP) and the percentage of patients with reduction of BP ⩾ 10 mmHg (d10_OSBP, d10_ODBP, d10_24-h SBP, d10_24-h DBP).
Results:
ICG-guided therapy was shown to be superior to the empiric approach, especially in MI_BP. In this subgroup, the BP reduction in HD was higher than in GE: d_OSBP (23.3 ± 10.8 versus 18.5 ± 13.9 mmHg; p = 0.035), d_ODBP (16.0 ± 6.3 versus 11.6 ± 9.6 mmHg; p = 0.003), d_24-h SBP (17.7 ± 10.8 versus 13.1 ± 13.1 mmHg; p = 0.035). This benefit was also confirmed by a higher percentage of patients with significant BP reduction: d10_OSBP (87.7% versus 69.1%; p = 0.012), d10_ODBP (69.2% versus 47.3%; p = 0.012) and d10_24-h SBP (72.3% versus 52.7%; p = 0.012). The comparison in the SI_BP subgroup did not reveal such significant differences.
Conclusions:
The hemodynamically guided pharmacotherapy results in greater BP reduction. This effect is more pronounced in patients with higher baseline BP, while in those with slightly increased BP the empiric approach seems comparable to ICG.
Related Concept Videos
Antihypertensive Drugs: Vasodilators
Hypertension V: Nursing Management
Hypertension IV: Drug Therapy and Lifestyle Modifications
Antihypertensive Drugs: Action of Diuretics
Hypertension and Regulation of Blood Pressure
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...

